These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Safety of a higher loading dose of phenobarbital in the term newborn. Donn SM, Grasela TH, Goldstein GW. Pediatrics; 1985 Jun; 75(6):1061-4. PubMed ID: 4000780 [Abstract] [Full Text] [Related]
6. Decreased phenobarbital absorption with charcoal administration for chronic renal failure. Tanaka C, Yagi H, Sakamoto M, Koyama Y, Ohmura T, Ohtani H, Sawada Y. Ann Pharmacother; 2004 Jan; 38(1):73-6. PubMed ID: 14742799 [Abstract] [Full Text] [Related]
7. Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis. Arimori K, Nakano M. J Pharmacobiodyn; 1986 May; 9(5):437-41. PubMed ID: 3761133 [Abstract] [Full Text] [Related]
17. Bumetanide potentiates the anti-seizure and disease-modifying effects of midazolam in a noninvasive rat model of term birth asphyxia. Welzel B, Johne M, Löscher W. Epilepsy Behav; 2023 May; 142():109189. PubMed ID: 37037061 [Abstract] [Full Text] [Related]
18. A combination of phenobarbital and the bumetanide derivative bumepamine prevents neonatal seizures and subsequent hippocampal neurodegeneration in a rat model of birth asphyxia. Johne M, Käufer C, Römermann K, Gailus B, Gericke B, Löscher W. Epilepsia; 2021 Jun; 62(6):1460-1471. PubMed ID: 33955541 [Abstract] [Full Text] [Related]